Annual Current Assets
$2.05 M
-$1.76 M-46.24%
31 December 2023
Summary:
XTL Biopharmaceuticals annual total current assets is currently $2.05 million, with the most recent change of -$1.76 million (-46.24%) on 31 December 2023. During the last 3 years, it has fallen by -$4.08 million (-66.57%). XTLB annual current assets is now -92.16% below its all-time high of $26.10 million, reached on 31 December 2006.XTLB Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$2.55 M
+$502.00 K+24.54%
31 March 2024
Summary:
XTL Biopharmaceuticals quarterly total current assets is currently $2.55 million, with the most recent change of +$502.00 thousand (+24.54%) on 31 March 2024. Over the past year, it has increased by +$265.00 thousand (+11.61%). XTLB quarterly current assets is now -92.24% below its all-time high of $32.82 million, reached on 30 June 2006.XTLB Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XTLB Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -46.2% | +11.6% |
| 3 y3 years | -66.6% | -60.6% |
| 5 y5 years | -75.0% | -67.8% |
XTLB Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -67.2% | at low | -60.6% | +24.5% |
| 5 y | 5 years | -75.0% | at low | -67.8% | +24.5% |
| alltime | all time | -92.2% | +396.6% | -92.2% | +1200.0% |
XTL Biopharmaceuticals Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $2.55 M(+24.5%) |
| Dec 2023 | $380.00 K(0.0%) | $2.05 M(-10.4%) |
| Sept 2023 | - | $2.28 M(-8.7%) |
| June 2023 | - | $2.50 M(-15.0%) |
| Mar 2023 | - | $2.94 M(-22.7%) |
| Dec 2022 | $380.00 K(-0.3%) | $3.81 M(-15.7%) |
| Sept 2022 | - | $4.52 M(-16.0%) |
| June 2022 | - | $5.38 M(-13.8%) |
| Mar 2022 | - | $6.24 M(+0.0%) |
| Dec 2021 | $381.00 K(-0.3%) | $6.24 M(-3.6%) |
| Sept 2021 | - | $6.47 M(-1.5%) |
| June 2021 | - | $6.57 M(-5.2%) |
| Mar 2021 | - | $6.93 M(+13.2%) |
| Dec 2020 | $382.00 K(0.0%) | $6.12 M(+5.0%) |
| Sept 2020 | - | $5.83 M(-9.1%) |
| June 2020 | - | $6.41 M(-7.0%) |
| Mar 2020 | - | $6.89 M(+0.8%) |
| Dec 2019 | $382.00 K(+0.5%) | $6.83 M(-13.6%) |
| Sept 2019 | - | $7.91 M(-13.7%) |
| June 2019 | - | $9.17 M(-23.9%) |
| Mar 2019 | - | $12.05 M(+47.1%) |
| Dec 2018 | $380.00 K(0.0%) | $8.20 M(+15.6%) |
| Sept 2018 | - | $7.09 M(+17.1%) |
| June 2018 | - | $6.06 M(+0.1%) |
| Mar 2018 | - | $6.05 M(-2.5%) |
| Dec 2017 | $380.00 K(+44.5%) | $6.21 M(-3.7%) |
| Sept 2017 | - | $6.44 M(-5.1%) |
| June 2017 | - | $6.79 M(-8.3%) |
| Mar 2017 | - | $7.41 M(+168.9%) |
| Dec 2016 | $263.00 K(-75.1%) | $2.75 M(-6.1%) |
| Sept 2016 | - | $2.93 M(-8.8%) |
| June 2016 | - | $3.22 M(-11.5%) |
| Mar 2016 | - | $3.64 M(-14.7%) |
| Dec 2015 | $1.06 M | $4.26 M(-11.5%) |
| Sept 2015 | - | $4.82 M(-8.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2015 | - | $5.26 M(+199.9%) |
| Mar 2015 | - | $1.75 M(-43.5%) |
| Dec 2014 | $2.54 M(-13.1%) | $3.10 M(-20.5%) |
| Sept 2014 | - | $3.90 M(-11.9%) |
| June 2014 | - | $4.42 M(-7.6%) |
| Mar 2014 | - | $4.79 M(-5.9%) |
| Dec 2013 | $2.93 M(-59.9%) | $5.09 M(-8.3%) |
| Sept 2013 | - | $5.55 M(+113.0%) |
| June 2013 | - | $2.60 M(-21.8%) |
| Mar 2013 | - | $3.33 M(-12.2%) |
| Dec 2012 | $7.29 M(+3127.4%) | $3.79 M(+10.5%) |
| Sept 2012 | - | $3.43 M(-5.1%) |
| June 2012 | - | $3.62 M(-11.6%) |
| Mar 2012 | - | $4.09 M(+173.8%) |
| Dec 2011 | - | $1.50 M(-19.6%) |
| Sept 2011 | - | $1.86 M(-15.7%) |
| June 2011 | - | $2.21 M(-14.1%) |
| Mar 2011 | - | $2.57 M(+141.1%) |
| Dec 2010 | - | $1.07 M(-23.6%) |
| Sept 2010 | - | $1.40 M(+612.2%) |
| June 2010 | - | $196.00 K(-41.5%) |
| Mar 2010 | - | $335.00 K(-18.7%) |
| Dec 2009 | - | $412.00 K(-45.0%) |
| Sept 2009 | - | $749.00 K(-74.4%) |
| Dec 2008 | - | $2.92 M(-68.0%) |
| June 2008 | - | $9.14 M(-34.2%) |
| Dec 2007 | $226.00 K(-71.9%) | $13.90 M(+4.3%) |
| June 2007 | - | $13.32 M(-49.0%) |
| Dec 2006 | $804.00 K(-40.9%) | $26.10 M(-20.5%) |
| June 2006 | - | $32.82 M(+138.0%) |
| Dec 2005 | $1.36 M(-26.5%) | $13.79 M(-25.9%) |
| June 2005 | - | $18.61 M(-21.7%) |
| Dec 2004 | $1.85 M(-1.8%) | $23.77 M(+63.6%) |
| June 2004 | - | $14.53 M |
| Dec 2003 | $1.89 M | - |
FAQ
- What is XTL Biopharmaceuticals annual total current assets?
- What is the all time high annual current assets for XTL Biopharmaceuticals?
- What is XTL Biopharmaceuticals annual current assets year-on-year change?
- What is XTL Biopharmaceuticals quarterly total current assets?
- What is the all time high quarterly current assets for XTL Biopharmaceuticals?
- What is XTL Biopharmaceuticals quarterly current assets year-on-year change?
What is XTL Biopharmaceuticals annual total current assets?
The current annual current assets of XTLB is $2.05 M
What is the all time high annual current assets for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high annual total current assets is $26.10 M
What is XTL Biopharmaceuticals annual current assets year-on-year change?
Over the past year, XTLB annual total current assets has changed by -$1.76 M (-46.24%)
What is XTL Biopharmaceuticals quarterly total current assets?
The current quarterly current assets of XTLB is $2.55 M
What is the all time high quarterly current assets for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high quarterly total current assets is $32.82 M
What is XTL Biopharmaceuticals quarterly current assets year-on-year change?
Over the past year, XTLB quarterly total current assets has changed by +$265.00 K (+11.61%)